lobbying_filings_raw: 3f10a316-e565-4ea3-aa28-a064a7e54a8a
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3f10a316-e565-4ea3-aa28-a064a7e54a8a | Q3 | 400693064 | RED+BLUE STRATEGIES | 194273 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2024 | third_quarter | 2024-10-05T12:31:06-04:00 | 70000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/3f10a316-e565-4ea3-aa28-a064a7e54a8a/", "filing_uuid": "3f10a316-e565-4ea3-aa28-a064a7e54a8a", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2024, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/3f10a316-e565-4ea3-aa28-a064a7e54a8a/print/", "filing_document_content_type": "text/html", "income": "70000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Melanie Nathanson", "dt_posted": "2024-10-05T12:31:06-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "601 13th Street NW", "registrant_address_2": "Suite 290 North", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 400693064, "url": "https://lda.senate.gov/api/v1/registrants/400693064/", "house_registrant_id": null, "name": "RED+BLUE STRATEGIES", "description": "Health Care Consulting", "address_1": "975 F St NW", "address_2": "Suite 550", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "MELANIE NATHANSON", "contact_telephone": "+1 202-258-9381", "dt_updated": "2026-02-25T17:01:10.141217-05:00"}, "client": {"id": 194273, "url": "https://lda.senate.gov/api/v1/clients/194273/", "client_id": 51, "name": "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)", "general_description": "PCMA represents pharmacy benefit managers, who administer the nation's covered Rx benefits", "client_government_entity": false, "client_self_select": false, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2011-01-14"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "H. R. 9747 - Continuing Appropriations and Extensions Act, 2025 - Issues related to funding government departments and agencies responsible for administering programs that support prescription drug coverage. CMS Rules and Regulations focused on the promulgation of the Medicare Part D program. S. 1542 - The DRUG Act - Issues related to ensuring that policies contemplated by Congress allow entities providing coverage of prescription medications have the tools they need to keep drugs affordable and accessible in the commercial market. H.R. 7623 - Telehealth Modernization Act of 2024 - Support for the underlying telemedicine extension, yet concern for the commercial delinking offset included in the legislation. S. 2973 - Modernizing and Ensuring PBM Accountability Act - Issues related to the important role PBMs play in keeping drug prices low for public and private employers and their employees. S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to pharmacy benefit managers and their role in keeping drug prices lower for patients. H.R. 3561 - The PATIENT Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. S. 1967 - The PBM Act - Issues related to delinking and limiting current tools used by PBMS to manage pharmacy benefits in Medicare. S. 1339 - The Pharmacy Benefit Manager Reform Act - Issues focused on limiting spread pricing and requiring rebate pass through and other tools used to control the price of prescription medications. S. 127 - The PBM Transparency Act - Issues related to the study of Pharmacy Benefit Managers by the Federal Trade Commission. S. 150 - Affordable Prescriptions for Patients Act - Issues related to ensuring that people's access to affordable medications are not impeded and innovations to ensure fair pricing structures are promulgated to their fullest. Issues related to prescription drug supply chain integrity and transparency. Issues related to the implementation of the Inflation Reduction Act for purposes of ensuring access to affordable medications for Medicare beneficiaries and people across the United States.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 54544, "prefix": "ms", "prefix_display": "MS.", "first_name": "MELANIE", "nickname": null, "middle_name": "JAN", "last_name": "NATHANSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 145382, "prefix": "ms", "prefix_display": "MS.", "first_name": "MEGAN", "nickname": null, "middle_name": "HAUCK", "last_name": "MARSHALL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "H. R. 9747 - Continuing Appropriations and Extensions Act, 2025 - Issues related to funding government departments and agencies responsible for administering programs that support prescription drug coverage. CMS Rules and Regulations focused on the promulgation of the Medicare Part D program. S. 1542 - The DRUG Act - Issues related to ensuring that policies contemplated by Congress allow entities providing coverage of prescription medications have the tools they need to keep drugs affordable and accessible in the commercial market. H.R. 7623 - Telehealth Modernization Act of 2024 - Support for the underlying telemedicine extension, yet concern for the commercial delinking offset included in the legislation. S. 2973 - Modernizing and Ensuring PBM Accountability Act - Issues related to the important role PBMs play in keeping drug prices low for public and private employers and their employees. S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to pharmacy benefit managers and their role in keeping drug prices lower for patients. H.R. 3561 - The PATIENT Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. S. 1967 - The PBM Act - Issues related to delinking and limiting current tools used by PBMS to manage pharmacy benefits in Medicare Issues related to prescription drug supply chain integrity and transparency. Issues related to the implementation of the Inflation Reduction Act for purposes of ensuring access to affordable medications for Medicare beneficiaries and people across the United States.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 54544, "prefix": "ms", "prefix_display": "MS.", "first_name": "MELANIE", "nickname": null, "middle_name": "JAN", "last_name": "NATHANSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 145382, "prefix": "ms", "prefix_display": "MS.", "first_name": "MEGAN", "nickname": null, "middle_name": "HAUCK", "last_name": "MARSHALL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "H. R. 9747 - Continuing Appropriations and Extensions Act, 2025 - Issues related to funding government departments and agencies responsible for administering programs that support prescription drug coverage. CMS Rules and Regulations focused on the promulgation of the Medicare Part D program. S. 1542 - The DRUG Act - Issues related to ensuring that policies contemplated by Congress allow entities providing coverage of prescription medications have the tools they need to keep drugs affordable and accessible in the commercial market. H.R. 7623 - Telehealth Modernization Act of 2024 - Support for the underlying telemedicine extension, yet concern for the commercial delinking offset included in the legislation. S. 2973 - Modernizing and Ensuring PBM Accountability Act - Issues related to the important role PBMs play in keeping drug prices low for public and private employers and their employees. S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to pharmacy benefit managers and their role in keeping drug prices lower for patients. H.R. 3561 - The PATIENT Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors. S. 1967 - The PBM Act - Issues related to delinking and limiting current tools used by PBMS to manage pharmacy benefits in Medicare. S. 1339 - The Pharmacy Benefit Manager Reform Act - Issues focused on limiting spread pricing and requiring rebate pass through and other tools used to control the price of prescription medications. S. 127 - The PBM Transparency Act - Issues related to the study of Pharmacy Benefit Managers by the Federal Trade Commission. S. 150 - Affordable Prescriptions for Patients Act - Issues related to ensuring that people's access to affordable medications are not impeded and innovations to ensure fair pricing structures are promulgated to their fullest. Issues related to prescription drug supply chain integrity and transparency. Issues related to the implementation of the Inflation Reduction Act for purposes of ensuring access to affordable medications for Medicare beneficiaries and people across the United States.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 54544, "prefix": "ms", "prefix_display": "MS.", "first_name": "MELANIE", "nickname": null, "middle_name": "JAN", "last_name": "NATHANSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 145382, "prefix": "ms", "prefix_display": "MS.", "first_name": "MEGAN", "nickname": null, "middle_name": "HAUCK", "last_name": "MARSHALL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | DC | US | US | PCMA represents pharmacy benefit managers, who administer the nation's covered Rx benefits | 0 | 0 | 645805 | normalized_name_state | 0.9 |